Register Online
 
Welcome
Scientific Programme
Plenary Speakers
Workshop Speakers
Key Dates
Committees
Registration
Accommodation
Travel Awards
Visa Information
Conference Tours
Social Programme
Sponsorship and Exhibition
Venue
Discover Sydney
General Information
Contact Us
 
 
 
 
 
Confirmed Plenary Speakers

Kari Alitalo
(Haartman Institute, University of Helsinki, Finland)

Topic:
Emerging developments in lymphangiogenesis

Takayuki AsaharaTakayuki Asahara
(RIKEN Center for Developmental Biology, Japan)

Topic:
Cell therapy and gene therapy using endothelial progenitor cells for vascular regeneration

Christer Betsholz
(Karolinska Institutet, Stockholm, Sweden)

Topic:
Notch signaling, tip cells and angiogenesis

Shaun Jackson
(Australian Centre for Blood Diseases, Box Hill, Australia)

Topic:
Growing complexity of platelet aggregation

Paul Kubes
(University of Calgary, Canada)

Topic:
Mechanisms of leukocyte recruitment in inflammation

Klaus Ley
(La Jolla Institute for Allergy and Immunology, CA, USA)

Topic:
How monocytes and lymphocytes enter the artery wall

Peter Libby
(Brigham and Women’s Hospital, Harvard Medical School, Boston, USA)

Topic:
Molecular imaging of proteinases in matrix mutant mice

Jake Lusis
(UCLA, USA)

Topic:
Genetics and susceptibility in atherosclerosis: a systems approach

Christina Mitchell
(Monash University, Australia)

Topic:
Phosphoinositide signalling

Ryozo Nagai
(University of Tokyo, Japan)

Topic:
KLF5, a key transcriptional factor which regulates SMC phenotypic modulation and metabolic syndrome

Janet Rossant
(Hospital for Sick Children, Toronto, Canada)

Topic:
Signaling pathways in early vascular development

Timothy Springer
(Immune Disease Institute, Harvard Medical School, Boston, USA)

Topic:
Integrin regulation and signalling

Brant Weinstein
(NICHA, Bethesda, USA)

Topic:
Assembly and patterning of vessels during developmental angiogenesis and lymphangiogenesis

Seppo Yla-HerttualaSeppo Yla-Herttuala
(University of Kuopio, Finland)

Topic:
Emerging developments in cardiovascular gene therapy